HomeCompareBKQNY vs JNJ

BKQNY vs JNJ: Dividend Comparison 2026

BKQNY yields 4.58% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKQNY wins by $3788.65M in total portfolio value
10 years
BKQNY
BKQNY
● Live price
4.58%
Share price
$9.48
Annual div
$0.43
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3788.68M
Annual income
$3,636,312,836.71
Full BKQNY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BKQNY vs JNJ

📍 BKQNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKQNYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKQNY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKQNY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKQNY
Annual income on $10K today (after 15% tax)
$389.70/yr
After 10yr DRIP, annual income (after tax)
$3,090,865,911.20/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BKQNY beats the other by $3,090,861,925.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKQNY + JNJ for your $10,000?

BKQNY: 50%JNJ: 50%
100% JNJ50/50100% BKQNY
Portfolio after 10yr
$1894.35M
Annual income
$1,818,158,763.06/yr
Blended yield
95.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BKQNY
No analyst data
Price Target
$6.79
-28.4% upside vs current
Range: $6.79 — $6.79
Altman Z
0.1
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKQNY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKQNYJNJ
Forward yield4.58%2.13%
Annual dividend / share$0.43$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$3788.68M$30.3K
Annual income after 10y$3,636,312,836.71$4,689.40
Total dividends collected$3777.92M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$6.79$228.73

Year-by-year: BKQNY vs JNJ ($10,000, DRIP)

YearBKQNY PortfolioBKQNY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,617$916.94$10,592$272.30+$1.0KBKQNY
2$14,421$1,991.03$11,289$357.73+$3.1KBKQNY
3$20,051$4,619.89$12,123$472.89+$7.9KBKQNY
4$33,460$12,006.16$13,141$629.86+$20.3KBKQNY
5$73,253$37,450.13$14,408$846.81+$58.8KBKQNY
6$231,628$153,247.58$16,021$1,151.60+$215.6KBKQNY
7$1,153,590$905,748.71$18,122$1,588.22+$1.14MBKQNY
8$9,666,036$8,431,694.41$20,930$2,228.20+$9.65MBKQNY
9$142,398,565$132,055,905.81$24,792$3,191.91+$142.37MBKQNY
10$3,788,679,301$3,636,312,836.71$30,274$4,689.40+$3788.65MBKQNY

BKQNY vs JNJ: Complete Analysis 2026

BKQNYStock

Bank of Queensland Limited, together with its subsidiaries, provides various financial products and services in Australia. The company operates in Retail Banking, BOQ Business, and Other segments. It offers personal banking services comprises savings and term deposits, and transactional accounts; debit and credit cards; home, personal, and car loans; and travel, home and content, landlord, and car insurance, as well as investment services comprising online share trading services, and self-managed superannuation funds. The company's business banking services include transaction accounts, and savings and investment accounts; loans and finance products, such as business loans, equipment and vehicle finance, and dealer finance; merchant and payment products; and financial market and international services. It also offers internet and mobile banking services. As of August 31, 2022, the company operated 36 corporate branches; 111 owner managed branches; and 7 transaction centers. Bank of Queensland Limited was founded in 1874 and is based in Newstead, Australia.

Full BKQNY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BKQNY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKQNY vs SCHDBKQNY vs JEPIBKQNY vs OBKQNY vs KOBKQNY vs MAINBKQNY vs ABBVBKQNY vs MRKBKQNY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.